Total raised
$100.4M
Last: Undisclosed 2017-08
Stage
Acquired
Founded
1998
Headcount
85
HQ
Migdal HaEmek
Sector
Health Tech & Life Sciences
About
Enzymotec is a biotechnology company that develops and produces biofunctional ingredients designed to address the health needs of everyone from babies to senior citizens. Enzymotecs nutrition and pharmaceutical business segments leverage the companys expertise in lipids. The nutrition segment manufactures lipid-based ingredients for use in products such as infant formula, nutritional supplements, and other dietary needs. The companys VAYA pharmaceutical segment makes and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases, including for the cardiovascular and neurological markets. Enzymotec is a fully owned subsidiary of Frutarom.
Funding history · 5 rounds · $100.4M total
2017-08
Undisclosed
$12.9M
2012-01
Series B
$10.0M
2009-02
Series B
$11.0M
2001-06
Undisclosed
$2.0M
2000-01
Undisclosed
$1.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C
Tags
seniorsadhdnutritionbiotechnologysupplementspharmaceuticalsbabiesfoodtechnovel-ingredientsfood-and-beveragepharma-companies